Group items tagged

The AAAS Early Career Award for Public Engagement with Science, established in 2010, recognizes early-career scientists and engineers who demonstrate excellence in their contribution to public engagement with science activities. A monetary prize of $5,000, a commemorative plaque, complimentary registration to the AAAS Annual Meeting, and reimbursement for reasonable hotel and travel expenses to attend the AAAS Annual Meeting to receive the prize are given to the recipient. Nominee must be an early-career scientist or engineer in academia, government or industry actively conducting research in any scientific discipline (including social sciences and medicine).  "Early career" is defined as an individual who has been in his/her current field for less than seven years and pre-tenure or job equivalent. Post-doctoral students are eligible for this award. Nominee will have demonstrated excellence in his/her contribution to public engagement with science activities, with a focus on interactive dialogue between the individual and a non-scientific, public audience(s). Types of public engagement activities might include: informal science education, public outreach, public policy, and/or science communication activities, such as mass media, public dialogue, radio, TV and film, science café, science exhibit, science fair, and social and online media.

The United States Agency for International Development (USAID) plans to provide up to $40 million in total USAID funding over a period of five-years. The purpose of the activity is to increase utilization of FP services through universal health coverage. It will be accomplished through: 1) strengthening capacity to more effectively train medical providers and community health workers in FP in both the public and private sectors; and, 2) focusing and expanding public sector FP information and services to high need groups such as adolescents, youth, newlyweds, and postpartum girls and women. The results this activity will achieve include: 1. Increased qualified FP workforce in public and private sectors, and 2. Increased availability of public sector FP outreach contacts and services, particularly for adolescents and youth.

The CDC, Division of Cancer Prevention and Control (DCPC) announces the availability of Fiscal Year 2019 funds to implement DP19-1905, The CDC Cancer Genomics Program: Translating Research into Public Health Practice. This program addresses the utilization of cancer genetic services as a strategy for cancer prevention and control. The primary outcomes of this NOFO are to increase screening of cancer family history and to increase the use of genetic counseling and testing for Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome (LS) among individuals meeting recommendations for referral. This funding opportunity supports the implementation and evaluation of public health activities within four core strategies to build the evidence base and disseminate best practices. These priorities will be accomplished by funding up to 5 awardees to develop, implement, and evaluate state-level programs in cancer genomics. Funding will support applicants that demonstrate: Appropriate experience with surveillance systems, partners and similar work in cancer genomics Appropriate organizational capacity to perform, implement, and evaluate activities and strategies An approach that is consistent with the strategies and outcomes described in the NOFO An ability to collect data towards key performance measures and outcomes Innovative methods and approaches to program and strategy implementation

The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. Those individuals should be exceptionally talented scientists who have demonstrated that they are the "best and brightest" of their peers. Applicants for this award must exhibit a strong desire to pursue a career in breast cancer research. Under this award mechanism, the postdoctoral fellow is considered the Principal Investigator (PI) and, as such, should write the project narrative, training plan, and other application components with appropriate guidance from the mentor. While the PI is not required to have previous experience in breast cancer research, the proposed project and training must focus on breast cancer. Applications must emphasize the PI's high potential for success in becoming an independent breast cancer researcher based on his/her qualifications, achievements (including first-author publications), and letters of recommendation. The mentor (or co-mentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include publications and active peer reviewed breast cancer funding, and clearly demonstrate a commitment to guiding the PI's research and training. If the mentor is not an experienced breast cancer researcher, then formal co-mentorship by an established breast cancer researcher is required. The application must include information about the mentor's experience in conducting innovative research and how he/she intends to support the PI's endeavors in breast cancer. 

A cancer survivor is a person diagnosed with cancer, from the time of diagnosis throughout the person’s lifespan. As of 2008, nearly 12 million cancer survivors were living in the United States; this number is expected to increase to 18 million in 2020. Cancer survivors have long-term adverse physical and psychosocial effects from their diagnosis and treatment, and have a greater risk for additional cancer diagnoses compared with persons without a cancer history. Cancer survivors commonly report negative behavioral, medical, and health care access issues that may contribute to poor long-term medical and psychosocial outcomes. An analysis of over 45,000 U.S. cancer survivors showed that: 1) 15% of cancer survivors continue to use tobacco; 2) 20-25% do not receive recommended cancer screenings; 3) 31% do not engage in any leisure time physical activity; 4) 40 to 50% do not receive flu or pneumonia vaccines; 5) 60% do not have a summary of their cancer treatment; and 6) 25% do not have any instructions (written or oral) for their treatment or follow-up care . CDC’s National Comprehensive Cancer Control Program (NCCCP) supports collaborative cancer control and prevention efforts in all states, the District of Columbia, tribal organizations, territories, and Pacific Island jurisdictions to address the cancer burden in their jurisdictions. In 2010, NCCCP developed six priorities areas of focus for the greatest public health impact; one of the six priorities is to address the public health needs of cancer survivors. The purpose of this FOA is to implement a broad set of evidence-based survivorship strategies in a subset of NCCCP grantees that will have the short-term results of increasing knowledge of cancer survivor needs, increasing survivor knowledge of treatment and follow-up care, and increasing provider knowledge of guidelines pertaining to treatment of cancer. Intermediate outcomes include the development of best practices in survivorship among NCCCP gra

A cancer survivor is a person diagnosed with cancer, from the time of diagnosis throughout the person’s lifespan. As of 2008, nearly 12 million cancer survivors were living in the United States; this number is expected to increase to 18 million in 2020. Cancer survivors have long-term adverse physical and psychosocial effects from their diagnosis and treatment, and have a greater risk for additional cancer diagnoses compared with persons without a cancer history. Cancer survivors commonly report negative behavioral, medical, and health care access issues that may contribute to poor long-term medical and psychosocial outcomes. An analysis of over 45,000 U.S. cancer survivors showed that: 1) 15% of cancer survivors continue to use tobacco; 2) 20-25% do not receive recommended cancer screenings; 3) 31% do not engage in any leisure time physical activity; 4) 40 to 50% do not receive flu or pneumonia vaccines; 5) 60% do not have a summary of their cancer treatment; and 6) 25% do not have any instructions (written or oral) for their treatment or follow-up care . CDC’s National Comprehensive Cancer Control Program (NCCCP) supports collaborative cancer control and prevention efforts in all states, the District of Columbia, tribal organizations, territories, and Pacific Island jurisdictions to address the cancer burden in their jurisdictions. In 2010, NCCCP developed six priorities areas of focus for the greatest public health impact; one of the six priorities is to address the public health needs of cancer survivors. The purpose of this FOA is to implement a broad set of evidence-based survivorship strategies in a subset of NCCCP grantees that will have the short-term results of increasing knowledge of cancer survivor needs, increasing survivor knowledge of treatment and follow-up care, and increasing provider knowledge of guidelines pertaining to treatment of cancer. Intermediate outcomes include the development of best practices in survivorship among NCCCP gra

The FY19 PRCRP Idea Award with Special Focus supports innovative, untested, high-risk/ potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to active duty Service members, Veterans, other military beneficiaries, and the American public. The "Special Focus" of this award mechanism is on exposures, conditions, or circumstances that are unique to the military, disproportionately represented in a military beneficiary population, or may affect force readiness. Cancers or circumstances with cancer risk that may affect the Service members' support system (military families) are of special importance for total mission readiness. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active duty Service members, Veterans, other military beneficiaries, and the American public. Relevance to military health should be articulated with respect to the overall MHS, the FY19 PRCRP Military Health Focus Areas in Section II.A.2, and the mission of the DHP and the FY19 PRCRP.

Scientists and patient advocacy groups often use a series of photos, commissioned by NEI some thirty years ago, when they wish to depict the visual experience of patients suffering from blinding diseases. At the time they were created, these images reflected the field's understanding of visual perception for such patients. But the field has advanced considerably since then, and these static images are considered overly simplistic, inaccurate, and generally unsatisfactory. At the same time, technology has evolved to where it is possible to use video and virtual reality to more authentically demonstrate (or even simulate) the experience of have a blinding disease. As part of the efforts of the NEI 50th Anniversary Planning Committee, the institute seeks the support of experts in blinding diseases, visual psychophysics, and video/virtual reality production to create a scientifically accurate and clinically authentic blindness simulation "experience" that can be used for education, public advocacy, and research purposes and a series of short videos that can be posted online for education and public outreach.

The reproducibility and comparability of research on dietary supplements is enhanced by rigorous analytical characterization of key experimental materials and the publication of validated analytical methods that accurately and precisely characterized and quantify constituents in dietary supplement ingredients and products. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods. The methods proposed for validation must be used to identify and quantify dietary supplement-relevant chemical constituents (i.e., active or marker chemical compounds, adulterants, contaminants) or their metabolites in experimental reagents, raw materials, and/or clinical specimens (e.g., urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grant's specific aims. Candidate constituents for quantitative method validation studies include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA.

The FY17 PRCRP Idea Award with Special Focus supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to active duty Service members, Veterans, other military beneficiaries, and the American public. The "Special Focus" of this award mechanism is on exposures, conditions, or circumstances that are unique to the military, disproportionately represented in a military beneficiary population, or may affect mission readiness. Cancers or circumstances with cancer risk that may affect military families are of special importance to the care and well-being of the military for total mission readiness. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System is critical to active duty Service members, Veterans, other military beneficiaries, and the American public.

Alex's Lemonade Stand Foundation, a nonprofit foundation that has evolved from a young cancer patient's front-yard lemonade stand to a national foundation for childhood cancer, awards grants designed to fill critical voids in current pediatric cancer research. Through its Innovation Grants program, the foundation awards two-year grants of up to $250,000 to researchers with a novel approach to pediatric oncology scientific investigation. That can include a change in research direction and/or an innovative new idea that moves away from an investigator's prior research but has potential impact for childhood cancers. Innovation Grants will support research proposals to be carried out by investigators who are already established, have a track record of peer-reviewed publications, and can demonstrate evidence of having successfully competed for extramural funding.

Alex's Lemonade Stand Foundation, a nonprofit foundation that has evolved from a young cancer patient's front-yard lemonade stand to a national foundation for childhood cancer, awards grants designed to fill critical voids in current pediatric cancer research. Through its Innovation Grants program, the foundation awards two-year grants of up to $250,000 to researchers with a novel approach to pediatric oncology scientific investigation. That can include a change in research direction and/or an innovative new idea that moves away from an investigator's prior research but has potential impact for childhood cancers. Innovation Grants will support research proposals to be carried out by investigators who are already established, have a track record of peer-reviewed publications, and can demonstrate evidence of having successfully competed for extramural funding.

The AACR NextGen Grants for Transformative Cancer Research represent the AACR's flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence. The grants provide $450,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students (including tuition costs), and research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.

The AACR NextGen Grants for Transformative Cancer Research represent the AACR's flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence. The grants provide $450,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students (including tuition costs), and research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.

Sociologists for Women in Society (SWS) works to improve women's lives through advancing and supporting feminist sociological research, activism and scholars. SWS is a nonprofit, scientific and educational organization with members in the U.S. and overseas. Its mission is to promote and disseminate research about women; educate colleagues, the general public, and government officials about the implications of research on women; offer help and mutual support to women and men who share the organization's concerns; take political action to improve women's lives; and maintain relationships with national and international organizations for women and the ending of discrimination against women.

The Alfred P. Sloan Foundation makes grants on six broad subject matters, known within the Foundation as major program areas.  Basic Research STEM Higher Education Public Understanding of Science Economic Performance and the Quality of Life Select National Issues Civic Initiatives

The purpose of the program is to identify international cancer control practices that can be applied to our domestic programs. Program activities will focus on 1) the establishment or strengthening of high quality cancer registries through establishment of centers for excellence in U.S. territories and other CDC global focus regions, 2) technical exchanges between CDC and the awardee, 3) consultations from global experts to help inform CDC's priority cancer activities, and 4) collaboration on the development and dissemination of monographs and other publications that promote evidence-based prevention for cervical (and other HPV-related), breast, lung, skin, colorectal and other types of cancer. Together, these activities represent an important opportunity for CDC to strengthen its programs in cancer prevention and control.

The Fellowships team of UICC is pleased to announce the call for proposals for the 2013 Yamagiwa-Yoshida Memorial International Cancer Study Grants. Please note that the application closing date is set to 1st July 2013. Please find below some key information regarding the fellowship:  WHAT 3 months International Fellowship Award value of USD 10,000 AIMS to initiate, set-up or pursue bilateral cancer research projects with collaborating investigators abroad to receive training in advanced experimental research methods and techniques to exploit complementary skills and material WHO  Individuals with: scientific or medical qualifications and a minimum of two years postdoctoral experience actively engaged in cancer research  have recent publications in the international peer-reviewed literature

The American Association for Cancer Research established this award in 2007 in honor of Margaret Foti, Ph.D., M.D. (h.c.), for her exemplary leadership of the AACR as its chief executive officer; for her sustained, outstanding work in fostering research, scholarly communications, education and training, science policy and public education; and for her extraordinary dedication and contributions to the conquest of cancer. This award recognizes a true champion of cancer research, an individual who embodies the sustained commitment of Margaret Foti to the prevention and cure of cancer. The award is given to an individual whose leadership and extraordinary achievements in cancer research or in support of cancer research have made a major impact on the field. Such achievements include contributions to the acceleration of progress in cancer research, raising national or international awareness of cancer research, or other demonstrations of a sustained commitment to the conquest of cancer.

The prestigious Pezcoller Foundation-AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown: who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research; who continues to be active in cancer research and has a record of recent, noteworthy publications; and whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.

The Pancreatic Cancer Action Network-AACR Innovative Grants represent a joint effort to promote and support innovative pancreatic cancer research. They aim to spur creative and cutting-edge ideas and approaches in pancreatic cancer research, including those successful in other areas of cancer that have justifiable promise for pancreatic cancer. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. These grants are available to full time, independent junior and senior investigators, including those with experience in other areas of cancer or biomedical/health science research who have promising ideas and approaches that can be applied to pancreatic cancer research. The grants provide $200,000 over two years ($100,000 per year) for direct and indirect expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators (grant recipient/collaborator salaries limited to 20 percent of the total grant), postdoctoral or clinical research fellows, graduate students and/or research assistants, research/laboratory supplies, equipment and publication charges for manuscripts that pertain directly to the funded project. It is anticipated that multiple Innovative Grants will be funded.

The AACR-Millennium Fellowship in Lymphoma Research represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct lymphoma-based research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to lymphoma. The fellowship provides a one-year grant of $55,000 to support the salary and benefits of the fellow while working on mentored lymphoma-related research. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project and other research expenses. It is anticipated that three fellowships will be funded.